Implications of the COVID-19 pandemic on MS services and treatment
Are people with multiple sclerosis at higher risk of developing a chronic or more severe coronavirus infection, and what are the implications for treatment?
Brownlee, et al. Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic. Neurology. 2020; doi: 10.1212/WNL.0000000000009507.
Dr Wallace Brownlee has received speaker honoraria and/or acted as a consultant for Biogen, Merck, Novartis, Roche and Sanofi-Genzyme. Case reports and social media editor for Multiple Sclerosis Journal.